دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of contents
doi : 10.1016/S0190-9622(23)03244-9
Volume 90, Issue 2, February 2024, Pages A4, A6-A7, A10-A12, A14, A16, A18, A20, A22, A24-A25
Information for readers
doi : 10.1016/S0190-9622(23)03245-0
Volume 90, Issue 2, February 2024, Page A26
JAAD Case Reports article list
doi : 10.1016/S0190-9622(23)03246-2
Volume 90, Issue 2, February 2024, Pages A27-A29
Journal based CME instructions and information
doi : 10.1016/S0190-9622(23)03247-4
Volume 90, Issue 2, February 2024, Page A30
Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon
Paul Curtiss, MD, a Katerina Svigos, MD, a Zachary Schwager, MD, b Kristen Lo Sicco, MD, a and Andrew G. Franks, Jr, MD
doi : 10.1016/j.jaad.2022.06.1199
Volume 90, Issue 2, February 2024, Pages 223-234
Answers to CME examination
doi : 10.1016/j.jaad.2023.12.002
Volume 90, Issue 2, February 2024, Page 236
Part II: The treatment of primary and secondary Raynaud's phenomenon
Paul Curtiss, MD, a Katerina Svigos, MD, a Zachary Schwager, MD, b Kristen Lo Sicco, MD, a and Anrdew G. Franks, Jr, MD
doi : 10.1016/j.jaad.2022.05.067
Volume 90, Issue 2, February 2024, Pages 237-248
Answers to CME examination
doi : 10.1016/j.jaad.2023.12.004
Volume 90, Issue 2, February 2024, Page 250
Copublication
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.06.037
Volume 90, Issue 2, February 2024, Page 251
This Month in JAAD: February 2024
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.11.022
Volume 90, Issue 2, February 2024, Page 252
This Month in JAAD Case Reports: February 2024 Chagas disease reactivation presenting with vasculitis
Brett Sloan, MD
doi : 10.1016/j.jaad.2023.11.033
Volume 90, Issue 2, February 2024, Page 253
This Month in JAAD International: February 2024: Atopic dermatitis and diabetes
Jonathan Kantor, MD, MSc, MSCE
doi : 10.1016/j.jaad.2023.12.006
Volume 90, Issue 2, February 2024, Page 254
Searching for a pox on the house of molluscum
Warren R. Heymann, MD
doi : 10.1016/j.jaad.2023.11.021
Volume 90, Issue 2, February 2024, Pages 255-256
Bridging the specialty gap: Update on primary cutaneous lymphomas
Elise A. Olsen, MD, a Emmilia Hodak, MD, b Larisa Geskin, MD, c and Julia Scarisbrick, MD d on behalf of the ISCL, USCLC, and EORTC-CLTG
doi : 10.1016/j.jaad.2023.10.007
Volume 90, Issue 2, February 2024, Pages 257-260
Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma
Nora A. Alexander, BS, a,b Stephanie K. Schaub, MD, c,d Peter H. Goff, MD, PhD, c Daniel S. Hippe, MS, d,y Song Y. Park, MD, a Kristina Lachance, MS, a Marika Bierma, a Jay J. Liao, MD, c Smith Apisarnthanarax, MD, c Shailender Bhatia, MD, d,e Yolanda D. Tseng, MD, c,d Paul T. Nghiem, MD, PhD, a and Upendra Parvathaneni, MBBS
doi : 10.1016/j.jaad.2023.07.1047
Volume 90, Issue 2, February 2024, Pages 261-268
Best practices in the treatment of melasma with a focus on patients with skin of color
Seemal R. Desai, MD, a,b Andrew F. Alexis, MD, MPH, c Nada Elbuluk, MD, d Pearl E. Grimes, MD, e Jonathan Weiss, MD, f Iltefat H. Hamzavi, MD, g and Susan C. Taylor, MD
doi : 10.1016/j.jaad.2023.07.1045
Volume 90, Issue 2, February 2024, Pages 269-279
Gender differences in pediatric and adolescent melanoma: A retrospective analysis of 4645 cases
Jennifer M. Fernandez, MD, RD, a Jenna E. Koblinski, MD, b Sabrina Dahak, MD, MS, c Clara Curiel-Lewandrowski, MD, d and Rebecca Thiede, MD
doi : 10.1016/j.jaad.2023.09.049
Volume 90, Issue 2, February 2024, Pages 280-287
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma
Guihong Wan, PhD, a,b,c Bonnie W. Leung, MD, a Mia S. DeSimone, MD, MPH, d Nga Nguyen, MD, MPH, a Ahmad Rajeh, MS, a Michael R. Collier, BS, a Hannah Rashdan, BS, a Katie Roster, MS, a Xu Zhou, MS, a,e Cameron B. Moseley, BS, a Ajit J. Nirmal, PhD, b Roxanne J. Pelletier, MS, b Zoltan Maliga, PhD, b Gyorgy Marko-Varga, PhD, f Istvan Balazs Nemeth, MD, PhD, g Hensin Tsao, MD, PhD, a Maryam M. Asgari, MD, a,h Alexander Gusev, PhD, i Anna M. Stagner, MD, j Christine G. Lian, MD, d Marc S. Hurlbert, PhD, k Feng Liu, PhD, e Kun-Hsing Yu, MD, PhD, c,d Peter K. Sorger, PhD, b and Yevgeniy R. Semenov, MD, MA
doi : 10.1016/j.jaad.2023.08.105
Volume 90, Issue 2, February 2024, Pages 288-298
Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials
Jeffrey L. Sugarman, MD, a Adelaide Hebert, MD, b John C. Browning, MD, MBA, c Amy S. Paller, MD, d Stephen Stripling, MD, e Lawrence J. Green, MD, f Martina Cartwright, PhD, g Carolyn Enloe, MPH, g Nick Wells, MSc, h and Tomoko Maeda-Chubachi, MD, PhD, MBA
doi : 10.1016/j.jaad.2023.09.066
Volume 90, Issue 2, February 2024, Pages 299-308
JAAD Game Changer: Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion
Wendi E. Wohltmann, MD
doi : 10.1016/j.jaad.2023.08.015
Volume 90, Issue 2, February 2024, Page 308
Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy
Cristina Faldetta, MD, a Shaniko Kaleci, PhD, a Johanna Chester, BA, BBS, a Cristel Ruini, MD, b,c Silvana Ciardo, BS, a Marco Manfredini, MD, a Stefania Guida, MD, PhD, d,e Camilla Chello, MD, c Carmen Cantisani, MD, PhD, c Jade N. Young, BS, f Patricia Cabral, MD, f Nicholas Gulati, MD, PhD, f Emma Guttman-Yassky, MD, PhD, f Giovanni Pellacani, MD, c and Francesca Farnetani, MD
doi : 10.1016/j.jaad.2023.09.084
Volume 90, Issue 2, February 2024, Pages 309-318
More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020
Margo J. Reeder, MD, a Donglin Zhang, BA, a Srikanth R. Aravamuthan, BS, a Erin M. Warshaw, MD, MS, b,c,d Joel G. DeKoven, MD, e Jonathan I. Silverberg, MD, PhD, MPH, f Brandon L. Adler, MD, g Amber R. Atwater, MD, h James S. Taylor, MD, i Marie-Claude Houle, MD, j Donald V. Belsito, MD, k Jiade Yu, MD, l Nina Botto, MD, m Christen M. Mowad, MD, n Cory A. Dunnick, MD, o,p Vincent A. DeLeo, MD, g and Melanie D. Pratt, MD
doi : 10.1016/j.jaad.2023.10.032
Volume 90, Issue 2, February 2024, Pages 319-327
JAAD Game Changer: Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
Jane Margaret Grant-Kels, MD
doi : 10.1016/j.jaad.2023.08.017
Volume 90, Issue 2, February 2024, Page 327
Survival outcomes of rare cutaneous malignancies within an insured cohort of patients, 1988-2018
Amanda Rosenthal, MD, a Margit Juhasz, MD, MSc, a,b Jing Zhang, MS, c Iesha Ticknor, BS, d Nima Gharavi, MD, PhD, b and Jeremy Man, MD
doi : 10.1016/j.jaad.2023.08.087
Volume 90, Issue 2, February 2024, Pages 328-338
Dermatology's role in the fight against human trafficking: A report from the AAD Ad Hoc Task Force and call to action
Samara Pollock, MD, a Sarah Ferree, MD, b Megan Cronin, MD, c Abigail M. Judge, PhD, d Diane S. Berson, MD, e Paul M. Friedman, MD, f Pearl E. Grimes, MD, g Jenny E. Murase, MD, h,i Esther E. Freeman, MD, PhD, j Medha Rao, PharmD, k Sameer Malik, MD, MBA, l Rosie Balk, MA, l Jeffrey Miller, PhD, l Terrence A. Cronin, Jr, MD, m and Arianne Shadi Kourosh, MD, MPH
doi : 10.1016/j.jaad.2023.08.093
Volume 90, Issue 2, February 2024, Pages 339-341
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
Dawn M. R. Davis, MD (Co-Chair), a Aaron M. Drucker, MD, ScM, b,c Ali Alikhan, MD, d Lionel Bercovitch, MD, e David E. Cohen, MD, MPH, f Jennifer M. Darr, LCSW, g Lawrence F. Eichenfield, MD, h Lindsy Frazer-Green, PhD, i Amy S. Paller, MD, j Kathryn Schwarzenberger, MD, k Jonathan I. Silverberg, MD, PhD, MPH, l Anne Marie Singh, MD, m Peggy A. Wu, MD, MPH, n and Robert Sidbury, MD, MPH (Co-Chair)
doi : 10.1016/j.jaad.2023.08.102
Volume 90, Issue 2, February 2024, Pages e43-e56
Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
Dawn M. R. Davis, MD (Co-Chair), a Aaron M. Drucker, MD, ScM, b,c Ali Alikhan, MD, d Lionel Bercovitch, MD, e David E. Cohen, MD, MPH, f Jennifer M. Darr, LCSW, g Lawrence F. Eichenfield, MD, h Lindsy Frazer-Green, PhD, i Amy S. Paller, MD, j Kathryn Schwarzenberger, MD, k Jonathan I. Silverberg, MD, PhD, MPH, l Anne Marie Singh, MD, m Peggy A. Wu, MD, MPH, n and Robert Sidbury, MD, MPH (Co-Chair) o
doi : 10.1016/j.jaad.2023.08.103
Volume 90, Issue 2, February 2024, Pages 342-345
JAAD Game Changer: ‘‘Use of oral antidepressants in patients with chronic pruritus: A systematic review
Andrew T. Patterson, MD
doi : 10.1016/j.jaad.2023.08.033
Volume 90, Issue 2, February 2024, Page 345
Commitment to leadership development for underrepresented in medicine dermatologists
Ellen N. Pritchett, MD, MPH, a Kelly M. Cordoro, MD, b Linda A. Ayers, BA, c and Olayemi Sokumbi, MD
doi : 10.1016/j.jaad.2023.10.002
Volume 90, Issue 2, February 2024, Pages 346-348
JAAD Game Changer: ‘‘Psoriasis and suicidality: A systematic review and meta-analysis
Andrew Patterson, MD
doi : 10.1016/j.jaad.2023.08.034
Volume 90, Issue 2, February 2024, Page 348
A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies
Joseph F. Merola, MD, MMSc, a Soumya D. Chakravarty, MD, PhD, b,c Olivia Choi, MD, PhD, b Daphne Chan, PhD, b and Alice B. Gottlieb, MD, PhD
doi : 10.1016/j.jaad.2023.10.021
Volume 90, Issue 2, February 2024, Pages 349-357
Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses
Annie Dai, MD, and Soo Jung Kim, MD, PhD
doi : 10.1016/j.jaad.2023.05.074
Volume 90, Issue 2, February 2024, Pages 358-367
JAAD Game Changer: ‘‘Systematic review and meta- analysis of the association between psoriasis and metabolic syndrome’’
Andrew Patterson, MD
doi : 10.1016/j.jaad.2023.08.035
Volume 90, Issue 2, February 2024, Page 367
Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
Wen-Kuan Huang, MD, PhD, a,b Hung-Chih Hsu, MD, PhD, a Tsai-Sheng Yang, MD, a Chun-Wei Lu, MD, c,d,e Yi-Ru Pan, PhD, b Chiao-En Wu, MD, PhD, a Wen-Hung Chung, MD, PhD, c,d,f Shuen-Iu Hung, PhD, f,g and Chun-Nan Yeh, MD b
doi : 10.1016/j.jaad.2023.06.055
Volume 90, Issue 2, February 2024, Pages 368-369
Clinicopathologic features, delayed diagnosis, and survival in amelanotic acral melanoma: A comparative study with pigmented melanoma
Qingrong Wu, BS, a,b,c,d,e,f,g Jie Pan, BS, a,b,c,d,e,f,g Wenrui Lin, BS, a,b,c,d,e,f,g Shuang Zhao, MD, a,b,c,d,e,f,g Mingliang Chen, MD, a,b,c,d,e,f,g Lixia Lu, MD, a,b,c,d,e,f,g Xiang Chen, MD, a,b,c,d,e,f,g and Juan Su, MD
doi : 10.1016/j.jaad.2023.08.083
Volume 90, Issue 2, February 2024, Pages 369-372
Predictive value of excision site bacterial burden and development of surgical site infection: A retrospective cohort study
Colleen Silva, MD, a Christen Samaan, MD, b Norhan Shamloul, MD, b Payvand Kamrani, DO, b Haorui Sun, BS, c Rebecca Urbonas, BS, d Allen Kunselman, MA, e and Klaus Helm, MD
doi : 10.1016/j.jaad.2023.07.1042
Volume 90, Issue 2, February 2024, Pages 372-374
Incidence and characteristics of acral lentiginous melanoma in Asian Americans and Pacific Islanders
Angela H. Wei, BS, a David X. Zheng, BA, a Christopher R. Cullison, MD, a Jeffrey F. Scott, MD, b and Bryan T. Carroll, MD, PhD
doi : 10.1016/j.jaad.2023.09.024
Volume 90, Issue 2, February 2024, Pages 374-376
Dermatological toxicities induced by T-cell-redirecting G protein-coupled receptor family C class 5 member D bispecific antibody talquetamab
Marion Lery, MD, a Aurore Perrot, MD, PhD, b Ariadna Ortiz-Brugues, MD, PhD, a Emmanuelle Vigarios, MD, PhD, c Diana Anghel, MD, a Pierre Bories, MD, PhD, b and Vincent Sibaud, MD
doi : 10.1016/j.jaad.2023.08.094
Volume 90, Issue 2, February 2024, Pages 376-377
Results of a treatment algorithm for generalized granuloma annulare
Juliana Berk-Krauss, MD, David Weiner, AB, and Misha Rosenbach, MD
doi : 10.1016/j.jaad.2023.09.050
Volume 90, Issue 2, February 2024, Pages 377-380
Differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients
Angela H. Wei, BS, a Lauren S. Fane, BSE, a Raghav Tripathi, MD, MPH, b and Jeremy S. Bordeaux, MD, MPH
doi : 10.1016/j.jaad.2023.09.051
Volume 90, Issue 2, February 2024, Pages 380-382
Development and validation of a caregiver-reported Numeric Rating Scale for measuring worst scratch/itch in patients aged 6Â months to younger than 6Â years with atopic dermatitis
Amy S. Paller, MD, a,b Elaine Siegfried, MD, c,d Servando E. Marron, MD, e,f Marci Clark, PharmD, g Dana DiBenedetti, PhD, h Lauren Nelson, PhD, h Jingdong Chao, PhD, i Ashish Bansal, MD, j Chien-Chia Chuang, PhD, k and Zhixiao Wang, PhD
doi : 10.1016/j.jaad.2023.08.104
Volume 90, Issue 2, February 2024, Pages 382-385
Anti-SS-A antibody is a potential predictor of severe Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study
Yuko Watanabe, MD, PhD, Tomoya Watanabe, MD, PhD, and Yukie Yamaguchi, MD, PhD
doi : 10.1016/j.jaad.2023.09.061
Volume 90, Issue 2, February 2024, Pages 385-387
Nonvisibility of suspicious lesions by patients leads to later detection of melanoma: A retrospective analysis
Emily Everdell, BA, a Hemali Shah, BS, BA, a Rose Parisi, MBA, a Paul J. Feustel, PhD, a and Lindy Davis, MD
doi : 10.1016/j.jaad.2023.09.064
Volume 90, Issue 2, February 2024, Pages 387-388
Risk of keratinocyte carcinomas following extracorporeal photopheresis among lung transplant recipients: A retrospective cohort study
David Z. Chen, BA, a Cynthia X. Wang, MD, b Julia B. Huecker, MS, a Aaron J. Russell, MD, b,c and Milan J. Anadkat, MD
doi : 10.1016/j.jaad.2023.09.067
Volume 90, Issue 2, February 2024, Pages 388-390
Health inequities in melanoma: A scoping review
Payton Clark, BA, BS, a Haley Howard, BS, a Elizabeth Garrett, BA, a Philo Waters, BS, a Kelsi Batioja, BS, a Mitchell Love, BS, a and Matt Vassar, PhD
doi : 10.1016/j.jaad.2023.09.068
Volume 90, Issue 2, February 2024, Pages 390-392
Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review
Nawar Tarafdar, BSc, a Muskaan Sachdeva, MD, b Iryna Savinova, BSc, c Yuliya Lytvyn, MD, PhD, b Khalad Maliyar, MD, b Jorge R. Georgakopoulos, MD, b Asfandyar Mufti, MD, b and Jensen Yeung, MD
doi : 10.1016/j.jaad.2023.09.070
Volume 90, Issue 2, February 2024, Pages 392-395
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial
Jannik Rousel, MSc, a,b Menthe E. Bergmans, MD, a,c Laura W. J. van der Meulen, MD, a,d Lisa Pagan, MD, a,c Digna T. de Bruin, MD, a,c Marieke L. de Kam, MSc, a Naomi B. Klarenbeek, MD, PhD, a Joke A. Bouwstra, PhD, b Marieke M. B. Seyger, Fig 1. Efficacy of guselkumab and long-term remission in patients with mild psoriasis compared with placebo. A, Efficacy expressed as mean absolute Psoriasis Area and Severity Index and 95% CI over time for patients randomized to guselkumab (n ¼ 15) or placebo (n ¼ 5). Patients were administered guselkumab 100 mg or placebo at day 0 (dose #1), week 4 (dose #2), and week 12 (dose #3). P values denote significant differences between the guselkumab and placebo group from the results of a mixed-effects model and are reported as *P # .05, **P # .01, ***P # .001. B, Time until patient-reported relapse in weeks after withdrawal from guselkumab therapy. Patients are stratified in their corresponding response group based on their Psoriasis Area and Severity Index score at the end of the treatment period at week 24. J AM ACAD D ERMATOL F EBRUARY 2024 396 Research Letters MD, PhD, e Juul M. P. A. van den Reek, MD, PhD, e Tessa Niemeyer-van der Kolk, MD, PhD, a Robert Rissmann, PhD, a,b,c and Martijn B. A. van Doorn, MD, PhD a,d and the NGID consortium
doi : 10.1016/j.jaad.2023.09.071
Volume 90, Issue 2, February 2024, Pages 395-397
Assessing the ability of an artificial intelligence chatbot to translate dermatopathology reports into patient-friendly language: A cross-sectional study
Yuying Zhang, BS, a Ryan Chen, BA, a Dan Nguyen, BS, a Stephanie Choi, BS, a Colleen Gabel, MD, b Nicholas Leonard, MD, b Kaitlyn Yim, MD, c Patrick O’Donnell, DO, c Zendee Elaba, MD, c April Deng, MD, PhD, c and Nikki A. Levin, MD, PhD
doi : 10.1016/j.jaad.2023.09.072
Volume 90, Issue 2, February 2024, Pages 397-399
Solid and hematological malignancies in patients with bullous pemphigoid: A national cohort study
Outi Varpuluoma, MD, PhD, a Jari Jokelainen, MSc, b Laura Huilaja, MD, PhD, a and Kaisa Tasanen, MD, PhD
doi : 10.1016/j.jaad.2023.09.073
Volume 90, Issue 2, February 2024, Pages 399-401
Association between inflammatory bowel disease and rosacea: A bidirectional two-sample Mendelian randomization study
Sihao Shen, BA, a Xingyue Gao, BA, a Xiuzu Song, PhD, b and Wenzhong Xiang, PhD
doi : 10.1016/j.jaad.2023.10.003
Volume 90, Issue 2, February 2024, Pages 401-403
Prevalence of palmoplantar pustulosis in the United States using the All of Us Research database
Olivia Kam, BA, a Shaina E. George, BS, b Sara Osborne, BS, c Brandon Smith, BA, d Shivani Thacker, DO, e Carolynne Vo, BS, f Raquel Wescott, BS, g and Jashin J. Wu, MD
doi : 10.1016/j.jaad.2023.08.110
Volume 90, Issue 2, February 2024, Pages 403-405
Prevalence of calcinosis cutis in the United States using the All of Us research database
Olivia Kam, BA, a Sara Osborne, BS, b Raquel Wescott, BS, c Carolynne Vo, BS, d Shivani Thacker, DO, e Shaina E. George, BS, f and Jashin J. Wu, MD
doi : 10.1016/j.jaad.2023.09.076
Volume 90, Issue 2, February 2024, Pages 405-406
Change in disease activity needed for meaningful change in cutaneous lupus by patient characteristic: A retrospective analysis of a longitudinal database
Julianne Kleitsch, BA, a,b Rachita Pandya, BA, a,b Srita Chakka, MD, a,b Daisy Yan, MD, a,b Darosa Lim, MD, a,b DeAnna Diaz, DO, a,b Rui Feng, PhD, c and Victoria P. Werth, MD
doi : 10.1016/j.jaad.2023.09.077
Volume 90, Issue 2, February 2024, Pages 406-408
Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation
Madison Hackley, MD,a Daphne Thampy, MPH, MD, a Shayan Waseh, MPH, MD, a Steven R. Feldman, MD, PhD, b Andrew Blauvelt, MD, MBA, c Jeffrey M. Weinberg, MD, d Sergio Schwartzman, MD, e Wilson Liao, MD, f Ronald Prussick, MD, g Jeffrey M. Cohen, MD, h Sylvia Hsu, MD, a and National Psoriasis Foundation Medical Board
doi : 10.1016/j.jaad.2023.09.078
Volume 90, Issue 2, February 2024, Pages 408-410
Geographic access to dermatologic care in urban underserved communities
Leilani Roberson, MD, a Pearl Ugwu-Dike, MD, b Philip A. Stevenson, MS, c and Sigrid M. Collier, MD, MPH
doi : 10.1016/j.jaad.2023.09.079
Volume 90, Issue 2, February 2024, Pages 410-412
Birt-Hogg-Dubé syndrome in skin of color: Literature review
Angel D. Pagan, BS, a,b Ashley Obi, BA, a,c Jayvon McKinley, BS, a Esther Oladunjoye, BA, MS, a Israel Kasago, MD, a Nicholas Gulati, MD, PhD, a Robert G. Phelps, MD, a and Cula Svidzinski, MD, PhD
doi : 10.1016/j.jaad.2023.09.081
Volume 90, Issue 2, February 2024, Pages 412-414
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
Alexander J. Stratigos, MD, PhD, a Aleksandar Sekulic, MD, b Ketty Peris, MD, c Oliver Bechter, MD, d Sorilla Prey, MD, e Karl D. Lewis, MD, f Nicole Basset-Seguin, PhD, g Anne Lynn S. Chang, MD, h Stephane Dalle, MD, i Almudena Fernandez Orland, MD, j Lisa Licitra, MD, k Caroline Robert, PhD, l Claas Ulrich, MD, m Axel Hauschild, MD, n Michael R. Migden, MD, o Reinhard Dummer, MD, p Suk-Young Yoo, PhD, q Emmanuel Okoye, MBBS, MPH, q Ioannis Bassukas, MD, r Carmen Loquai, MD, s Vincenzo De Giorgi, MD, t Zeynep Eroglu, MD, u Ralf Gutzmer, MD, v Jens Ulrich, MD, w Susana Puig, MD, x Timothy J. Inocencio, PharmD, PhD
doi : 10.1016/j.jaad.2023.08.111
Volume 90, Issue 2, February 2024, Pages 414-418
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study
Guihong Wan, PhD, a,b Nga Nguyen, MD, MPH, a Bonnie W. Leung, MD, a Hannah Rashdan, BS, a Kimberly Tang, BA, a Katie Roster, MS, a Michael R. Collier, BS, a Pearl O. Ugwu-Dike, BS, a Neel S. Raval, BA, a Nora A. Alexander, BS, a Ruple Jairath, BS, a Jordan Phillipps, BS, a Munachimso Amadife, BS, a Shijia Zhang, MBI, a Alexander Gusev, PhD, c Steven T. Chen, MD, a Kerry L. Reynolds, MD, d Nicole R. LeBoeuf, MD, MPH, e Shawn G. Kwatra, MD, f and Yevgeniy R. Semenov, MD, MA
doi : 10.1016/j.jaad.2023.09.082
Volume 90, Issue 2, February 2024, Pages 418-420
Research letter: BRAF-inhibitor induced panniculitis - A systematic review
Yae Kye, BA, a,b Grant Zhao, BA, a Samantha Guhan, MD, a Denise Nunes, MS, RN, MSLIS, c and Cuong V. Nguyen, MD
doi : 10.1016/j.jaad.2023.10.008
Volume 90, Issue 2, February 2024, Pages 420-423
Improved homogeneity and monotonicity of American Joint Committee on Cancer staging manual, 8th edition on cutaneous squamous cell carcinoma with addition of poor differentiation
Neha Gupta, MD, MPH, a,b Patrick M. Mulvaney, MD, MPH, c Fadi Murad, MD, MPH, a Brian R. Gastman, MD, d Evelyn Ilori, MD, PhD, e Shlomo Koyfman, MD, f Chrysalyne D. Schmults, MD, MSCE, a Allison T. Vidimos, MD, g and Emily S. Ruiz, MD, MPH
doi : 10.1016/j.jaad.2023.10.009
Volume 90, Issue 2, February 2024, Pages 423-425
Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study
Michael Ong, BS, a Huongly Do, BS, a Benedict Ho, BA, a and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.10.010
Volume 90, Issue 2, February 2024, Pages 425-427
Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma
Emily Y. Kim, BS, a,b,c Emily S. Ruiz, MD, b,c,d Glenn J. Hanna, MD, d,e Manisha Thakuria, MD, b,c,d and Ann W. Silk, MD
doi : 10.1016/j.jaad.2023.10.011
Volume 90, Issue 2, February 2024, Pages 427-429
Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients
Francesc Alamon-Reig, MD, a Xavier Bosch-Amate, MD, a Priscila Giavedoni, MD, PhD, a Vasiliki Nikolaou, MD, PhD, b Cristina Mangas, MD, PhD, c Zoe Apalla, MD, PhD, d Ander Mayor, MD, e Chrysa Oikonomou, MD, f Michela Starace, MD, PhD, g,h Vincent Sibaud, MD, i and Cristina Carrera, MD, PhD
doi : 10.1016/j.jaad.2023.10.012
Volume 90, Issue 2, February 2024, Pages 429-432
Lack of skin of color reporting in disease severity rating tools used for inflammatory skin conditions: A scoping review
Arielle Carolina Mora Hurtado, BS, a and Justin O. Endo, MD, MHPE
doi : 10.1016/j.jaad.2023.09.083
Volume 90, Issue 2, February 2024, Pages 432-434
Patient-physician concordance in age, sex, and race is not associated with increased trust, satisfaction, empathy, or physician’s perception of a difficult patient in Singapore
Ellie Choi, MBBS, MRCP, a,b Kalyani Rajesh Patwardhan, MD, MRCP, a Valencia Long, MBBS, MRCP, a Yiong Huak Chan, PhD, c Yik Weng Yew, MBBS, PhD, d,e Hazel H. Oon, MD, MRCP, d Steven Thng, MBBS, MRCP, d Chris Tan, MBBS, a Nisha Suyien Chandran, MBBS, MRCP, a,b and Phillip Phan, PhD
doi : 10.1016/j.jaad.2023.10.022
Volume 90, Issue 2, February 2024, Pages 434-436
Analysis of metformin, niacinamide, and niacin as skin cancer preventative medications in solid organ transplant recipients
Ellie Choi, MBBS, MRCP, a,b Kalyani Rajesh Patwardhan, MD, MRCP, a Valencia Long, MBBS, MRCP, a Yiong Huak Chan, PhD, c Yik Weng Yew, MBBS, PhD, d,e Hazel H. Oon, MD, MRCP, d Steven Thng, MBBS, MRCP, d Chris Tan, MBBS, a Nisha Suyien Chandran, MBBS, MRCP, a,b and Phillip Phan, PhD
doi : 10.1016/j.jaad.2023.10.023
Volume 90, Issue 2, February 2024, Pages 436-438
Associations between ichthyosis and mood disorders: A case-control study in the All of Us Research Program
Gloria Chen, BA, a Mohamad Goldust, MD, b Keith A. Choate, MD, PhD, b,c,d and Jeffrey M. Cohen, MD
doi : 10.1016/j.jaad.2023.10.025
Volume 90, Issue 2, February 2024, Pages 439-440
Population sociodemographic and geographic factors associated with dermatologist distribution in the United States
Devin Genderson, a Jeromy W. Gotschall, BA, b Robert Fitzsimmons, MS, b Douglas J. Wiebe, PhD, c,d Daniel B. Shin, PhD, b and Junko Takeshita, MD, PhD, MSCE
doi : 10.1016/j.jaad.2023.10.027
Volume 90, Issue 2, February 2024, Pages 440-443
Defining clinically meaningful improvement in molluscum contagiosum
Tomoko Maeda-Chubachi, MD, PhD, MBA, a Lori McLeod, PhD, b Carolyn Enloe, MPH, a Martina Cartwright, PhD, a Elaine Siegfried, MD, c Adelaide A. Hebert, MD, d and Nanette Silverberg, MD
doi : 10.1016/j.jaad.2023.10.033
Volume 90, Issue 2, February 2024, Pages 443-445
An update on private equity acquisitions in dermatology, 2013 to 2022
Aneesh Agarwal, MBA, a * and Seth J. Orlow, MD, PhD
doi : 10.1016/j.jaad.2023.10.024
Volume 90, Issue 2, February 2024, Pages 446-448
Postoperative radiation therapy for Merkel cell carcinoma: The sooner, the better
Brent Moody, MD
doi : 10.1016/j.jaad.2023.09.016
Volume 90, Issue 2, February 2024, Page 449
Ethical issues surrounding a patient requesting inappropriate care
Alexander Gitin, BS, a Arthur M. Samia, MD, b Jane M. Grant-Kels, MD, c and Sami K. Saikaly, MD b
doi : 10.1016/j.jaad.2022.08.011
Volume 90, Issue 2, February 2024, Pages 450-451
JAAD Game Changer: “Autoimmune diseases in adults with atopic dermatitis�
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.051
Volume 90, Issue 2, February 2024, Page 451
Representation for all: Educational handouts inclusive of patient skin color in a nail specialty clinic
Rachel C. Hill, BS, a Eden Axler, BS, b Kaya L. Curtis, BA, a Apostolos Katsiaunis, BS, c and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.10.013
Volume 90, Issue 2, February 2024, Page e57
A novel method to clean hair follicular grafts in hair transplantation
Chi Liu, MD, a Qian Liu, BM, b Ying Zhang, BM, a Mei Zhang, BM, a Jiufu Zhang, BM, a and Wei Wu, PhD
doi : 10.1016/j.jaad.2022.04.003
Volume 90, Issue 2, February 2024, Pages e58-e59
A modified technique of subcision to prevent intraoperative spurt of blood
Bhavya Swarnkar, MD, Mohammed Thalha, MBBS, and Somesh Gupta, MD
doi : 10.1016/j.jaad.2022.04.033
Volume 90, Issue 2, February 2024, Pages e60-e61
Surgical pearl: Linear closures on the anterior lower leg
Lauren A. Fitzgerald, BS, a Remi K. Hamel, MD, b Elizabeth L. Hall, MD, b and Leonard H. Goldberg, MD
doi : 10.1016/j.jaad.2022.05.006
Volume 90, Issue 2, February 2024, Pages e62-e63
Adipose trimming and reducing risk of graft falling on the floor
Sam Fathizadeh, BS, a Jennifer N. Rorex, MD, b and Ramin Fathi, MD
doi : 10.1016/j.jaad.2022.09.017
Volume 90, Issue 2, February 2024, Pages e64-e65
Efficient suturing in herniating adipose with an assistant’s technique of tissue displacement
Scott J. Mahlberg, DO, Rebecca Sarac, MD, and Bryan T. Carroll, MD, PhD
doi : 10.1016/j.jaad.2022.09.041
Volume 90, Issue 2, February 2024, Page e66
Technical solution for reconstruction of upper lip defect by bilateral V-Y advanced flaps
Mengying Duan, MD, Chao Yue, MD, Yeqin Dai, MD, Yi Wu, MD, and Jianzhong Peng, MD
doi : 10.1016/j.jaad.2022.09.047
Volume 90, Issue 2, February 2024, Pages e67-e68
Use of a rubber fingerstall to dress wounds after a nail surgery
Yi Wu, MD, Yeqin Dai, MD, Mengying Duan, MD, and Jianzhong Peng, MD
doi : 10.1016/j.jaad.2022.10.030
Volume 90, Issue 2, February 2024, Pages e69-e70
Retroauricular hinge flaps for full-thickness conchal bowl defects
Jason C. Klein, MD, PhD, and Rajiv I. Nijhawan, MD
doi : 10.1016/j.jaad.2022.10.056
Volume 90, Issue 2, February 2024, Pages e71-e72
Ultraviolet photography in vitiligo using a smartphone camera attachment for checking sunscreen coverage
Reinhart Speeckaert, MD, PhD, and Nanja van Geel, MD, PhD
doi : 10.1016/j.jaad.2023.10.030
Volume 90, Issue 2, February 2024, Pages e73-e74
Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry
Yijun Wu, MD, a Kai Kang, MD, a Xu Sun, MD, b Ting Niu, MD, b and Ailin Zhao, MD
doi : 10.1016/j.jaad.2023.08.106
Volume 90, Issue 2, February 2024, Pages e75-e78
Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL
Madeline J. Hooper, MD, a Francesca L. Veon, DO, a Gail L. Enriquez, BS, b Morgan Nguyen, MD, a Cameron B. Grimes, BA, a Tessa M. LeWitt, MD, a Yanzhen Pang, BS, a Slaton Case, MD, a Jaehyuk Choi, MD, PhD, a Joan Guitart, MD, a Michael B. Burns, PhD, b and Xiaolong A. Zhou, MD, MSc
doi : 10.1016/j.jaad.2023.08.107
Volume 90, Issue 2, February 2024, Page e79
Comorbidities of psoriasis in underrepresented patient populations: An All of Us database analysis
Gaurav N. Pathak, PharmD, a,b Rithi J. Chandy, MS, a,b Suraj S. Pathak, BS, c Babar K. Rao, MD, a,d and Steven R. Feldman, MD, PhD
doi : 10.1016/j.jaad.2023.08.108
Volume 90, Issue 2, February 2024, Pages e80-e82
Response to letter to the editor “It’s time to consider a new topical algorithm for psoriasis�
Craig A. Elmets, MD, a Alan Menter, MD, b Sameer Malik, MD, MBA, c and David A. Castillo, BS
doi : 10.1016/j.jaad.2023.08.109
Volume 90, Issue 2, February 2024, Page e83
It is time to consider a new topical algorithm for psoriasis
Priya V. Engel, MPH, a Brandon Smith, BA, b Sogol Stephanie Javadi, BS, c and Jashin J. Wu, MD
doi : 10.1016/j.jaad.2023.07.1048
Volume 90, Issue 2, February 2024, Pages e84-e85
February 2024 IOTADERMA (#360)
Robert I. Rudolph, MD, FACP
doi : 10.1016/j.jaad.2023.08.024
Volume 90, Issue 2, February 2024, Page e86
